Pro-Change Behavior Systems, Inc. today announced they will work with Quintiles Medical Education, Consensus Medical Communications, and Medical Education Resources in 2009 to comprehensively measure outcomes for continuing medical education initiatives for the effective treatment of hepatitis C virus (HCV).
These initiatives will be delivered live, on-line, and via print. Consistent with the most recent Alliance for Continuing Medical Education competencies regarding partnering with external partners, Pro-Change will develop a common set of measures related to performance improvement in the treatment of HCV. These measures, based on the Transtheoretical Model (TTM) of Behavior Change, will be used for all of the educational activities developed by each partner in this unique collaboration.
The principles of the TTM will also be used to guide the inclusion of behavior change messaging within each CME activity.
The goal is to move CME to performance improvement, going beyond the traditional goal of improving knowledge. Including messages that match the readiness of the entire target audience is expected to increase effectiveness of CME activities for treatment of HCV. The overall educational initiatives are supported by an independent educational grant from Roche Pharmaceuticals.
David Schlumper of Quintiles stated that he “is confident that the collaboration with Pro-Change will bring about improvements in measuring and accomplishing performance improvements and will ultimately improve patient care.”
Becky Carney of Consensus Medical Communications stated that she “values the opportunity to partner with other CME stakeholders to take full advantage of the skills and resources of each group. This allows us to best support education that drives improvements in clinician behaviors which promote optimized patient outcomes.”